Wikisage, the free encyclopedia of the second generation, is digital heritage
Doripenem: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(→ATC) |
||
| Line 10: | Line 10: | ||
==ATC== | ==ATC== | ||
<ref>[https://karmel.miraheze.org/m/6Sy karnmel(miraheze) es:Doripenem]</ref> | <ref>[https://karmel.miraheze.org/m/6Sy karnmel(miraheze) es:Doripenem]</ref> | ||
{{refs}} | |||
Revision as of 15:15, 2 September 2021
Doripenem is a beta-lactam antibiotic agent belonging to the carbapenem group
|
Seizures have been reported during treatment with doripenem (see section 6.2). In clinical trials, doripenem-treated patients with pre-existing central nervous system (CNS) disorders (e.g. stroke or history of seizures), patients with compromised renal function and patients given doses greater than 500 mg every 8 hours appear to be at greater risk for developing seizures [1] |
ATC
| References: |